home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Developing, Implementing, and Evaluating Risk Minimization Action Plans (RiskMAPs)

 
  December 18, 2006  
     
 
Drug Information Association, Online
Jan 24 2007


This special webinar will provide expert insight into the challenges associated with the development, implementation, and evaluation of Risk Minimization Action Plans (RiskMAPs), strategic safety programs used to:
•Manage the challenge of incorporating drug safety into a product lifecycle
•Target one or more safety-related health outcomes or goals through the use of one or more tools including targeted education and outreach, reminder systems, and/or performance-linked access systems
•Meet specific goals and objectives in minimizing known risks of a product while preserving its benefits.
 
 
Organized by: Drug Information Association
Invited Speakers: JOYCE WEAVER,, Pharm D
Senior Drug Risk Management Analyst
FDA, CDER
Office of Surveillance and Epidemiology.
 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/product/13228/07201.pdf
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.